Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1994 | 03-1994 | 12-1993 | 09-1993 | 06-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,252 | 2,832 | 1,793 | 1,098 | 353 |
| Marketable Securities | 511 | 1,523 | 1,529 | 4,541 | 8,089 |
| Receivables | 5,224 | 4,257 | 2,727 | 2,275 | 5,182 |
| Inventories | 7,183 | 9,208 | 8,428 | 7,889 | 7,967 |
| Other current assets | 519 | 550 | 600 | 542 | 569 |
| TOTAL | $20,688 | $18,369 | $15,077 | $16,344 | $22,160 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 11,425 | N/A | N/A |
| Investments And Advances | 2,873 | 2,905 | 2,620 | 1,661 | 1,626 |
| Other Non-Current Assets | 1,241 | 1,324 | 1,298 | 2,214 | 2,361 |
| TOTAL | $4,114 | $4,228 | $15,343 | $3,874 | $3,987 |
| Total Assets | $30,054 | $27,925 | $24,378 | $25,772 | $31,692 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 298 | 298 | 298 | 280 | 280 |
| Accounts payable and accrued liabilities | 2,729 | 2,917 | 1,829 | 1,340 | 1,925 |
| Accrued Expenses | 1,851 | 1,822 | 2,077 | 1,070 | 761 |
| Other current liabilities | 7,823 | 894 | 6,317 | 6,163 | 1,670 |
| TOTAL | $12,700 | $13,947 | $10,521 | $8,853 | $12,211 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,143 | 3,303 | 3,355 | 3,476 | 3,591 |
| TOTAL | $3,143 | $3,303 | $3,355 | $3,476 | $3,591 |
| Total Liabilities | $15,843 | $17,249 | $13,876 | $12,328 | $15,802 |
| Shareholders' Equity | |||||
| Common Shares | 61,697 | 55,289 | 137 | 53,410 | 53,256 |
| Retained earnings | -47,667 | -44,862 | -43,012 | -39,966 | -37,366 |
| Other shareholders' equity | 181 | 249 | 2,300 | 0 | 0 |
| TOTAL | $14,211 | $10,676 | $10,501 | $13,444 | $15,890 |
| Total Liabilities And Equity | $30,054 | $27,925 | $24,377 | $25,772 | $31,692 |